Sharing our knowledge of melanoma on the global stage

Sharing our knowledge of melanoma on the global stage

20 April 2021

More than 2,000 clinicians and researchers from across the globe united online for the virtual 10th World Congress of Melanoma in conjunction with the 17th EADO Congress.

As leaders in the field of melanoma, many clinicians and researchers from Melanoma Institute Australia (MIA) shared their knowledge. This congress provides an opportunity to educate clinicians on the latest developments in our understanding and treatment of skin cancer.

Here are just a handful of the areas of melanoma research that we presented on:

  • Renowned pathologist and MIA’s Co-Medical Director, Prof Richard Scolyer, discussed how we can predict the likelihood that a patient’s disease will return by examining the molecular profile of their melanoma.
  • Medical Oncologist and MIA’s Co-Medical Director Prof Georgina Long AO delivered a keynote address discussing if a cure for advanced melanoma is on the horizon. She reviewed the recent advancements in drug development to treat advanced melanoma, as well as outlining the challenges we still face to overcome drug resistance. Prof Long also highlighted the importance of getting our prevention messaging across if we truly want to reach our goal of zero deaths from melanoma. 
  • Translational researcher Prof Helen Rizos will reviewed how circulating DNA in the bloodstream can be used as a marker to monitor disease and treatment response in patients with advanced melanoma. This minimally invasive technique can help monitor patients in real-time and is proving to be a valuable new tool to support the clinical care of patients with melanoma.
  • Dermatologist Prof Diona Damian presented an overview of nicotinamide (vitamin B3) as a preventative measure to reduce the incidence of non-melanoma skin cancers in high-risk patients.
  • Using clinical data alone can help predict which patients will respond well to treatment with immunotherapy. However, when Dr James Wilmott and our team of lab researchers examined biopsies taken from patients before immunotherapy, they found that biopsies showing higher numbers of immune cells touching the melanoma were associated with response and tumour shrinkage. Dr Wilmott shared these findings which will ultimately help select the ideal therapies for patients and will be incorporated into our Personalised Immunotherapy Platform.

Through the combined sharing of knowledge, it is inspiring to see the global commitment to enhancing our understanding of melanoma that will ultimately improve the care of melanoma patients.

#10thWCM

Australasian Melanoma Conference AMC2021
19 Nov - 20 Nov 2021

Australasian Melanoma Conference AMC2021

The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.

Australian researchers spearhead paradigm shift in melanoma treatment
20 Sep 2021

Australian researchers spearhead paradigm shift in melanoma treatment

Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread

Tags: melanoma
Melanoma March physical events in 2022
20 Sep 2021

Melanoma March physical events in 2022

We are excited to announce a return to our much-loved physical Melanoma March events in March 2022! 

Tags: melanoma
Melanoma Bike Bash 2021: What a ride!
20 Sep 2021

Melanoma Bike Bash 2021: What a ride!

Over two fun, yet challenging, days in September an intrepid group of riders and crew successfully completed the annual Melanoma Bike Bash in WA!

Tags: melanoma
Prof Georgina Long AO awarded inaugural Outstanding Female Researcher Medal from AAHMS
16 Sep 2021

Prof Georgina Long AO awarded inaugural Outstanding Female Researcher Medal from AAHMS

Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.

Tags: melanoma
MIA researchers awarded $7.2m in NHMRC grants for health research
15 Sep 2021

MIA researchers awarded $7.2m in NHMRC grants for health research

Three MIA researchers at University of Sydney received grants to further their important melanoma research.

Tags: melanoma
Amie St Clair Ball in Wagga postponed for a third time
06 Sep 2021

Amie St Clair Ball in Wagga postponed for a third time

COVID restrictions continue to impact fundraising for melanoma services in Riverina.

Honouring Ben's life by supporting the next generation of melanoma researchers
30 Aug 2021

Honouring Ben's life by supporting the next generation of melanoma researchers

Ben Garrow lost his life to melanoma. In his honour his family has established a scholarship to support a PhD student whose work focuses on saving lives from melanoma.

MIA's annual Research Retreat 2021
20 Aug 2021

MIA's annual Research Retreat 2021

More than 150 clinicians, researchers and MIA staff gathered online to share research highlights.

Understanding the needs of Stage III melanoma patients when choosing treatments.
28 Jul 2021

Understanding the needs of Stage III melanoma patients when choosing treatments.

Independent researchers at The University of Sydney are seeking patient feedback.

Community Fundraising Wrap Up Apr-June 2021
21 Jul 2021

Community Fundraising Wrap Up Apr-June 2021

A re-cap of the wonderful, and often very creative, community fundraising initiatives over the April to June quarter.

Tags: melanoma
Patients paying it forward
19 Jul 2021

Patients paying it forward

Our patients who donate their tissue samples and records to our research are helping to make a difference to the lives of future melanoma patients. 

Tags: melanoma
Research boost to improve outcomes for melanoma patients
15 Jul 2021

Research boost to improve outcomes for melanoma patients

MIA researchers have recently been awarded two competitive funding grants, which will help facilitate their ground-breaking work in melanoma research.

Tags: melanoma
Amie St Clair 10th Annual Ball
25 Jun 2022

Amie St Clair 10th Annual Ball

Celebrate the 10th anniversary of Amie St Clair Melanoma at the Annual Ball in Wagga Wagga!   

Riverina Melanoma Ride
31 Mar - 07 Apr 2022

Riverina Melanoma Ride

Postponed to early 2022. Melanoma survivor Matt Kean is doing a 1000km bike ride around the Riverina to increase awareness of melanoma and raise funds for Amie St Clair Melanoma - MIA. There are many ways you can be part of this life-changing ride!

Melanoma Clinical Trial opens in Wagga
23 Jun 2021

Melanoma Clinical Trial to open in Wagga

Riverina patients gain access to potentially life saving immunotherapy treatment close to home.

Tags: melanoma
Queen's Birthday Honour for Professor Richard Scolyer
13 Jun 2021

 Queen's Birthday Honour for Professor Richard Scolyer

MIA's Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia. 

Tags: melanoma
Sharing our research on the global stage at 2021 ASCO Annual Meeting
07 Jun 2021

Sharing our research on the global stage at 2021 ASCO Annual Meeting

Research from MIA was once again in the spotlight as findings were shared at the virtual ASCO21. 

Tags: melanoma
Australian researchers lead world in successful trial of new cancer treatment
03 Jun 2021

Australian researchers lead world in successful trial of new cancer treatment.

In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.

Tags: melanoma
Thank you doesn't seem enough for our melanoma nurses.
28 May 2021

Thank you doesn't seem enough for our melanoma nurses.

Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.

Tags: melanoma